PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

ledipasvir/sofosbuvir vs omeprazole

Side-by-side comparison of ledipasvir/sofosbuvir and omeprazole. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Proton-pump inhibitors (e.g., omeprazole) Proton-pump inhibitor doses comparable to omeprazole 20 mg or lower can be administered simultaneously with HARVONI under fasted conditions.

Recommendation: You may take these medicines at the same time on an empty stomach as long as the omeprazole dose is 20 mg or less.

Drug Class
ledipasvir/sofosbuvir NS5A/NS5B Inhibitor (HCV)
omeprazole Proton Pump Inhibitor (PPI)
Type
ledipasvir/sofosbuvir Prescription
omeprazole Over-the-Counter
Summary
ledipasvir/sofosbuvir

Harvoni is a medicine that contains ledipasvir and sofosbuvir. It is used to treat chronic hepatitis C virus (HCV) infection in adults and children 3 years and older.

omeprazole

Omeprazole (Prilosec) is a medicine that reduces the amount of acid in your stomach. It belongs to a class of drugs called proton pump inhibitors (PPIs).

What It Treats
ledipasvir/sofosbuvir

Harvoni treats chronic Hepatitis C virus (HCV) genotypes 1, 4, 5, or 6. It can be used if you don't have cirrhosis or if you have compensated cirrhosis. If you have genotype 1 with decompensated cirrhosis or are a liver transplant recipient with genotype 1 or 4, you will take Harvoni with another medicine called ribavirin.

omeprazole

This medicine treats frequent heartburn, which is heartburn that occurs 2 or more days a week. It is not meant to give you immediate relief from heartburn. It may take 1 to 4 days for the medicine to fully work.

How It Works
ledipasvir/sofosbuvir

Harvoni contains two medicines that stop the hepatitis C virus from multiplying in your body. Ledipasvir blocks a protein called NS5A. Sofosbuvir blocks another protein called NS5B.

omeprazole

Omeprazole works by blocking the production of acid in your stomach. It does this by targeting the cells that make stomach acid. This helps to reduce heartburn symptoms.

Common Side Effects
ledipasvir/sofosbuvir
  • Feeling tired
  • Headache
  • Feeling weak
  • Nausea
omeprazole
  • Headache
FAERS Reports
ledipasvir/sofosbuvir
  • Feeling tired 4,130
  • Headache 3,706
  • Nausea 1,240
  • Diarrhea 913
  • Hepatitis C 883
omeprazole
  • Tiredness 19,903
  • Feeling sick to your stomach 19,841
  • Loose stools 19,625
  • Difficulty breathing 16,336
  • Headache 14,629
Serious Warnings
ledipasvir/sofosbuvir

Harvoni can cause Hepatitis B to become active again if you have had it in the past. This can cause serious liver problems, including liver failure and death. Your doctor will test you for Hepatitis B before you start Harvoni and monitor you during and after treatment.

omeprazole

Children under 18 should ask a doctor before use. Heartburn in children may be a sign of a serious condition.

Pregnancy
ledipasvir/sofosbuvir

If you are pregnant or plan to become pregnant, talk to your doctor before taking Harvoni. If Harvoni is taken with ribavirin, it is unsafe during pregnancy. Talk to your doctor if you are breastfeeding or plan to breastfeed.

omeprazole

Talk to your doctor if you are pregnant or breastfeeding before taking this medicine. It is important to weigh the benefits and risks with your doctor.

Also Compare, Nearby Drugs

How to Read This ledipasvir/sofosbuvir vs omeprazole Comparison

ledipasvir/sofosbuvir is classified in the NS5A/NS5B Inhibitor (HCV) drug class, while omeprazole sits within the Proton Pump Inhibitor (PPI) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, ledipasvir/sofosbuvir has 10,872 submissions while omeprazole has 90,334. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to omeprazole lowers stomach acid, which can affect how well the body takes in the hepatitis c medicine.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between ledipasvir/sofosbuvir and omeprazole - always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.